Last day at the The Royal Society What a fantastic place to work!

Spent two glorious weeks exploring #Pakistan recently & the determination of the massively engaged people there to exercise their democratic right in the face of serious voter suppression and the threat of violence was inspiring #PakistanZindabad bbc.co.uk/news/live/worl…

EU to call for easier visas for scientists as UK rejoins Horizon on.ft.com/49t3suc

UK visa costs latest: Iliana Ivanova: “We are having some difficulties with European researchers going to the UK due to some visa issues and also higher costs that I’m going to raise with the British side” Difficulties: £20.9k up front for a family of four on a 5-yr visa…

Speaking about medicine shortages at this afternoons Health and Social Care Committee ABPI’s Rick Greville discussed how medicines manufacturers work hard to prevent and overcome any disruption to supply, but occasional shortages are unavoidable. In general, the medicine supply chain is

The ABPI has set out the measures the UK’s life sciences industry wants to see in Chancellor Sir Jeremy Hunt MP's Budget on 6 March. These are the 4 key areas where the Budget could boost UK life science success: ⚗️Enhance the UK’s long-term tax and fiscal offer to global and

Speaking on the how industrial policy can be used to build on the UK’s strengths and competitiveness Richard Torbett, ABPI Chief Executive, gave evidence at the Business and Trade Committee on the opportunities for the life sciences industry⬇️⬇️

And that’s a wrap on todays conference! A special thanks to all our speakers, to our fantastic exhibitors, our patient organisation partners, supporters and Ministers for coming, it’s been a great day! #ABPIConf24!

Important report out today on medicines discovery - we were pleased to partner with Medicines Discovery Catapult + BioIndustry Association (BIA) on it. Our Chief Executive Richard Torbett said: "For the UK to become a global life science superpower, we must create a conducive environment across all stages of medicine

Great to see Wes Streeting and Peter Kyle working on plans to make 🇬🇧 a life sciences powerhouse👏 We have a plan that can help - read it here abpi.org.uk/media/news/202…

this is a great report from IPPR which aligns strongly with Academy of Medical Sciences positions on research and public health's role in boosting the economy including recommendations around clinical research⬇️🏥 congrats to @cthomasippr and team!

Our President Russell Abberley of Amgen 🧪🔬🧬 says it’s crucial to recognise that the economic and health missions are interlinked. Ensuring that the UK’s competitive edge continues to be enhanced will be key to securing inward investment and fuelling growth. Labour Together #Lab24

Thank you to Department for Science, Innovation and Technology secretary Peter Kyle for dropping into our ABPI dinner at labour conference tonight. Look forward to working in partnership with DSIT & across government to continue to grow the UK’s fantastic life sciences sector. #LabConf24 The Labour Party

Life sciences is one of the crown jewels of the British economy. This landmark agreement will not only drive forward work that will boost our health, but will also fire up our economy, delivering the growth we need to invest further in health and to push up living standards.

I'm pleased LifeArc signed. It's easy to shout about your budget being cut - but there's more to it. R&D is like a bath. If you keep turning the tap on and off, you end up sitting in cold water. Remember ODA cuts? It was about more than money. It's a similar argument now.

.Cancer Research UK was one of the orgs via CaSE that wrote to the Chancellor cited on #BBCLaurak to warn about impact of rumoured cuts to R&D budget on research breakthroughs, patient benefit and growth sciencecampaign.org.uk/analysis-and-p… I talk more about this on Politics East this morn

🚨BUDGET UPDATE - Chancellor just said government is "protecting record funding for R&D to harness full potential for UK science base". #Budget2024

What shld be the top #LifeScience priorities for the new Govnt? VG to be back at #LifeScienceHouse, Bloomsbury to chair the #PharmaIntegrates2024 opening panel with #RozBecker, #RussAbberley & Nicola Blackwood to agree: 📊Data 🩺Prevention economics 🧪ClinicalTrials 💊Uptake

Watch this👇👇👇 Fantastic 2 minute summary of where we are with R&D funding post budget: what is welcome, what we still don’t know, and why it matters. Alicia Greated

Great discussions this morning with ABPI members and Alan Mak MP 🇬🇧 🏴󠁧󠁢󠁥󠁮󠁧󠁿 on how we can support cutting-edge science and economic growth in the UK.